Product / Service Summary

Cysal is using microbial metabolic diversity for the development of novel fermentation technologies and products. Key interest is harnessing microbial metabolic diversity for the development of novel industrial fermentation technologies and products.


Chemicals/Pharmaceuticals

Startup Stage

Manufacturing

B2B

Description

Advanced biotechnological fermentation strategies are increasingly replacing chemical approaches for the production of speciality and base commodities. This trend is set to continue with the increased demand for more sustainable alternatives to traditional industrial processes.

Cysal is a modern biotechnology company with a focus on developing, optimizing, and licensing fermentation technology solutions and novel applications for biopolymers and low-molecular weight compounds such as dipeptides.

Cysals own expertise in industrial biotechnology and our large and robust network of collaboration partners and institutions within Germany and abroad enable us to deliver solutions and products tailor-made to perfectly meet the requirements of our customers.


Cysal Funding


Cysal Team Members




Startbase Data

Added: 15.10.2019
Updated: 28.10.2019
  • Validated team members on Startbase
  • Registered at a German Handelsregister
  • Headquarter located in Germany
  • Scalable Business Model
  • Innovative Business Model

Cysal

Cysals key interest is harnessing microbial metabolic diversity for the development of novel industrial fermentation technologies and products